Stay updated on Pembrolizumab and Olaparib in BRCA Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and Olaparib in BRCA Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and Olaparib in BRCA Breast Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page revision label was updated to v3.4.3, replacing the previous v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-12T00:29:09.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    The study status was updated to Completed with actual completion dates, replacing the previous 'Active, not recruiting' status. The page revision was updated to v3.4.2 and the funding-status notice was removed.
    Difference
    0.8%
    Check dated 2026-02-11T11:43:11.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    A government funding status notice banner was added and the site revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T10:23:06.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Glossary toggle added; a new label 'Last Update Submitted that Met QC Criteria' appears and a 'No FEAR Act Data' notice is shown. The site revision is updated from v3.3.4 to v3.4.0.
    Difference
    0.2%
    Check dated 2026-01-28T05:56:22.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    Added Revision: v3.3.4 and removed Revision: v3.3.3. This is a minor metadata update with no impact on study details or user-facing content.
    Difference
    0.1%
    Check dated 2026-01-14T02:58:59.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    Added a dedicated Locations section with California (Los Angeles) at Cedars-Sinai Medical Center and updated the page revision to v3.3.3. The older California Locations entry, HHS Vulnerability Disclosure, and the prior v3.3.2 reference were removed.
    Difference
    0.2%
    Check dated 2025-12-23T13:37:18.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and Olaparib in BRCA Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Olaparib in BRCA Breast Cancer Clinical Trial page.